Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors

Biochimica et Biophysica Acta - Biomembranes

Volumn 1838, Issue 1 PARTA, 2014, Pages 15-33

  Sridharan, Rajashri ^a   Zuber, Jeffrey ^a   Connelly, Sara M ^a   Mathew, Elizabeth ^a   Dumont, Mark E ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Fluorescence; Fluorescence Resonance Energy Transfer; FRET; G protein coupled receptors; Ligands; Pheromone receptors

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND; MUTANT PROTEIN; PHEROMONE RECEPTOR;

BINDING SITE; CELL TYPE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; FLUORESCENCE SPECTROSCOPY; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY;

FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; FRET; G PROTEIN COUPLED RECEPTORS; LIGANDS; PHEROMONE RECEPTORS;

AMINO ACID SEQUENCE; FLUORESCENT DYES; KINETICS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, G-PROTEIN-COUPLED; X-RAY DIFFRACTION;

EID: 84888374656     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2013.09.005     Document Type: Review

References (332)

1. J.P. Overington, B. Al-Lazikani, and A.L. Hopkins How many drug targets are there? Nat. Rev. Drug Discov. 5 2006 993 996 (Pubitemid 44835126)
2. E. Reiter, S. Ahn, A.K. Shukla, and R.J. Lefkowitz Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors Annu. Rev. Pharmacol. Toxicol. 52 2012 179 197
3. A.K. Shukla, K. Xiao, and R.J. Lefkowitz Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling Trends Biochem. Sci. 36 2011 457 469
4. K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, B.A. Fox, I. Le Trong, D.C. Teller, T. Okada, R.E. Stenkamp, M. Yamamoto, and M. Miyano Crystal structure of rhodopsin: a G protein-coupled receptor Science 289 2000 739 745 (Pubitemid 30650186)
5. H.W. Choe, Y.J. Kim, J.H. Park, T. Morizumi, E.F. Pai, N. Krauss, K.P. Hofmann, P. Scheerer, and O.P. Ernst Crystal structure of metarhodopsin II Nature 471 2011 651 655
6. 2- adrenergic G protein-coupled receptor Science 318 2007 1258 1265 (Pubitemid 350172884)
7. 2 adrenoceptor complex Nature 469 2011 236 240
8. V.P. Jaakola, M.T. Griffith, M.A. Hanson, V. Cherezov, E.Y. Chien, J.R. Lane, A.P. Ijzerman, and R.C. Stevens The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist Science 322 2008 1211 1217
9. E.Y. Chien, W. Liu, Q. Zhao, V. Katritch, G.W. Han, M.A. Hanson, L. Shi, A.H. Newman, J.A. Javitch, V. Cherezov, and R.C. Stevens Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist Science 330 2010 1091 1095
10. B. Wu, E.Y. Chien, C.D. Mol, G. Fenalti, W. Liu, V. Katritch, R. Abagyan, A. Brooun, P. Wells, F.C. Bi, D.J. Hamel, P. Kuhn, T.M. Handel, V. Cherezov, and R.C. Stevens Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 330 2010 1066 1071
11. T. Shimamura, M. Shiroishi, S. Weyand, H. Tsujimoto, G. Winter, V. Katritch, R. Abagyan, V. Cherezov, W. Liu, G.W. Han, T. Kobayashi, R.C. Stevens, and S. Iwata Structure of the human histamine H1 receptor complex with doxepin Nature 475 2011 65 70
12. M.A. Hanson, C.B. Roth, E. Jo, M.T. Griffith, F.L. Scott, G. Reinhart, H. Desale, B. Clemons, S.M. Cahalan, S.C. Schuerer, M.G. Sanna, G.W. Han, P. Kuhn, H. Rosen, and R.C. Stevens Crystal structure of a lipid G protein-coupled receptor Science 335 2012 851 855
13. K. Haga, A.C. Kruse, H. Asada, T. Yurugi-Kobayashi, M. Shiroishi, C. Zhang, W.I. Weis, T. Okada, B.K. Kobilka, T. Haga, and T. Kobayashi Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist Nature 482 2012 547 551
14. A.C. Kruse, J. Hu, A.C. Pan, D.H. Arlow, D.M. Rosenbaum, E. Rosemond, H.F. Green, T. Liu, P.S. Chae, R.O. Dror, D.E. Shaw, W.I. Weis, J. Wess, and B.K. Kobilka Structure and dynamics of the M3 muscarinic acetylcholine receptor Nature 482 2012 552 556
15. S. Granier, A. Manglik, A.C. Kruse, T.S. Kobilka, F.S. Thian, W.I. Weis, and B.K. Kobilka Structure of the delta-opioid receptor bound to naltrindole Nature 485 2012 400 404
16. A. Manglik, A.C. Kruse, T.S. Kobilka, F.S. Thian, J.M. Mathiesen, R.K. Sunahara, L. Pardo, W.I. Weis, B.K. Kobilka, and S. Granier Crystal structure of the micro-opioid receptor bound to a morphinan antagonist Nature 485 2012 321 326
17. H. Wu, D. Wacker, M. Mileni, V. Katritch, G.W. Han, E. Vardy, W. Liu, A.A. Thompson, X.P. Huang, F.I. Carroll, S.W. Mascarella, R.B. Westkaemper, P.D. Mosier, B.L. Roth, V. Cherezov, and R.C. Stevens Structure of the human kappa-opioid receptor in complex with JDTic Nature 485 2012 327 332
18. J.F. White, N. Noinaj, Y. Shibata, J. Love, B. Kloss, F. Xu, J. Gvozdenovic-Jeremic, P. Shah, J. Shiloach, C.G. Tate, and R. Grisshammer Structure of the agonist-bound neurotensin receptor Nature 490 2012 508 513
19. C. Zhang, Y. Srinivasan, D.H. Arlow, J.J. Fung, D. Palmer, Y. Zheng, H.F. Green, A. Pandey, R.O. Dror, D.E. Shaw, W.I. Weis, S.R. Coughlin, and B.K. Kobilka High-resolution crystal structure of human protease-activated receptor 1 Nature 492 2012 387 392
20. C. Wang, Y. Jiang, J. Ma, H. Wu, D. Wacker, V. Katritch, G.W. Han, W. Liu, X.P. Huang, E. Vardy, J.D. McCorvy, X. Gao, X.E. Zhou, K. Melcher, C. Zhang, F. Bai, H. Yang, L. Yang, H. Jiang, B.L. Roth, V. Cherezov, R.C. Stevens, and H.E. Xu Structural basis for molecular recognition at serotonin receptors Science 340 2013 610 614
21. C. Wang, H. Wu, V. Katritch, G.W. Han, X.P. Huang, W. Liu, F.Y. Siu, B.L. Roth, V. Cherezov, and R.C. Stevens Structure of the human smoothened receptor bound to an antitumour agent Nature 497 2013 338 343
22. K. Hollenstein, J. Kean, A. Bortolato, R.K. Cheng, A.S. Dore, A. Jazayeri, R.M. Cooke, M. Weir, and F.H. Marshall Structure of class B GPCR corticotropin-releasing factor receptor 1 Nature 499 2013 438 443
23. 2-adrenergic receptor function Science 318 2007 1266 1273 (Pubitemid 350172885)
24. Y. Shibata, J.F. White, M.J. Serrano-Vega, F. Magnani, A.L. Aloia, R. Grisshammer, and C.G. Tate Thermostabilization of the neurotensin receptor NTS1 J. Mol. Biol. 390 2009 262 277
25. V. Katritch, V. Cherezov, and R.C. Stevens Structure-function of the g protein-coupled receptor superfamily Annu. Rev. Pharmacol. Toxicol. 53 2013 531 556
26. P. Leff The two-state model of receptor activation Trends Pharmacol. Sci. 16 1995 9
27. 2-adrenergic receptor. Extending the ternary complex model J. Biol. Chem. 268 1993 4625 4636 (Pubitemid 23081571)
28. T. Kenakin Functional selectivity through protean and biased agonism: who steers the ship? Mol. Pharmacol. 72 2007 1393 1401 (Pubitemid 350146075)
29. M.J. Lohse, S. Nuber, and C. Hoffmann Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling Pharmacol. Rev. 64 2012 299 336
30. K.D. Pfleger, and K.A. Eidne Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells Biochem. J. 385 2005 625 637 (Pubitemid 40208822)
31. N. Audet, C. Gales, E. Archer-Lahlou, M. Vallieres, P.W. Schiller, M. Bouvier, and G. Pineyro Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins J. Biol. Chem. 283 2008 15078 15088
32. C. Gales, J.J. Van Durm, S. Schaak, S. Pontier, Y. Percherancier, M. Audet, H. Paris, and M. Bouvier Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes Nat. Struct. Mol. Biol. 13 2006 778 786 (Pubitemid 44338771)
33. N.A. Lambert GPCR dimers fall apart Sci. Signal. 3 2010 pe12
34. S. Angers, A. Salahpour, and M. Bouvier Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function Annu. Rev. Pharmacol. Toxicol. 42 2002 409 435 (Pubitemid 34160532)
35. S. Terrillon, and M. Bouvier Roles of G-protein-coupled receptor dimerization EMBO Rep. 5 2004 30 34 (Pubitemid 38228524)
36. M.B. Dalrymple, K.D. Pfleger, and K.A. Eidne G protein-coupled receptor dimers: functional consequences, disease states and drug targets Pharmacol. Ther. 118 2008 359 371
37. M.J. Lohse Dimerization in GPCR mobility and signaling Curr. Opin. Pharmacol. 10 2010 53 58
38. V.V. Gurevich, and E.V. Gurevich How and why do GPCRs dimerize? Trends Pharmacol. Sci. 29 2008 234 240
39. S. Bulenger, S. Marullo, and M. Bouvier Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation Trends Pharmacol. Sci. 26 2005 131 137 (Pubitemid 40313592)
40. J.E. Slessareva, and H.G. Dohlman G protein signaling in yeast: new components, new connections, new compartments Science 314 2006 1412 1413 (Pubitemid 44871938)
41. S. Fields Pheromone response in yeast Trends Biochem. Sci. 15 1990 270 273
42. L. Bardwell, J.G. Cook, C.J. Inouye, and J. Thorner Signal propagation and regulation in the mating pheromone response pathway of the yeast Saccharomyces cerevisiae Dev. Biol. 166 1994 363 379
43. S.J. Dowell, and A.J. Brown Yeast assays for G protein-coupled receptors Methods Mol. Biol. 552 2009 213 229
44. 2- adrenergic receptor and Gs α subunit Science 250 1990 121 123 (Pubitemid 20374972)
45. A.J. Brown, S.L. Dyos, M.S. Whiteway, J.H. White, M.A. Watson, M. Marzioch, J.J. Clare, D.J. Cousens, C. Paddon, C. Plumpton, M.A. Romanos, and S.J. Dowell Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein α-subunit chimeras Yeast 16 2000 11 22 (Pubitemid 30066092)
46. B. Noble, L.A. Kallal, M.H. Pausch, and J.L. Benovic Development of a yeast bioassay to characterize G protein-coupled receptor kinases. Identification of an NH2-terminal region essential for receptor phosphorylation J. Biol. Chem. 278 2003 47466 47476 (Pubitemid 37523188)
47. N. Hao, N. Yildirim, Y. Wang, T.C. Elston, and H.G. Dohlman Regulators of G protein signaling and transient activation of signaling: experimental and computational analysis reveals negative and positive feedback controls on G protein activity J. Biol. Chem. 278 2003 46506 46515 (Pubitemid 37452223)
48. R.C. Yu, C.G. Pesce, A. Colman-Lerner, L. Lok, D. Pincus, E. Serra, M. Holl, K. Benjamin, A. Gordon, and R. Brent Negative feedback that improves information transmission in yeast signalling Nature 456 2008 755 761
49. T.M. Yi, H. Kitano, and M.I. Simon A quantitative characterization of the yeast heterotrimeric G protein cycle Proc. Natl. Acad. Sci. U. S. A. 100 2003 10764 10769 (Pubitemid 37140102)
50. E. Melamed, M. Lahav, and D. Atlas Beta-adrenergic receptors in rat myocardium: direct detection by a new fluorescent beta-blocker Experientia 32 1976 1387 1389
51. E. Melamed, M. Lahav, and D. Atlas Direct localisation of beta-adrenoceptor sites in rat cerebellum by a new fluorescent analogue of propranolol Nature 261 1976 420 422
52. D. Atlas, and A. Levitzki Probing of beta-adrenergic receptors by novel fluorescent beta-adrenergic blockers Proc. Natl. Acad. Sci. U. S. A. 74 1977 5290 5294
53. J.E. Niedel, I. Kahane, and P. Cuatrecasas Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils Science 205 1979 1412 1414 (Pubitemid 10226658)
54. L.A. Sklar, D.A. Finney, Z.G. Oades, A.J. Jesaitis, R.G. Painter, and C.G. Cochrane The dynamics of ligand-receptor interactions. Real-time analyses of association, dissociation, and internalization of an N-formyl peptide and its receptors on the human neutrophil J. Biol. Chem. 259 1984 5661 5669 (Pubitemid 14145029)
55. C.J. Daly, and J.C. McGrath Fluorescent ligands, antibodies, and proteins for the study of receptors Pharmacol. Ther. 100 2003 101 118 (Pubitemid 37377908)
56. J.C. McGrath, S. Arribas, and C.J. Daly Fluorescent ligands for the study of receptors Trends Pharmacol. Sci. 17 1996 393 399 (Pubitemid 26401695)
57. R.J. Middleton, and B. Kellam Fluorophore-tagged GPCR ligands Curr. Opin. Chem. Biol. 9 2005 517 525 (Pubitemid 41338206)
58. A. Waller, P.C. Simons, S.M. Biggs, B.S. Edwards, E.R. Prossnitz, and L.A. Sklar Techniques: GPCR assembly, pharmacology and screening by flow cytometry Trends Pharmacol. Sci. 25 2004 663 669 (Pubitemid 39458173)
59. K. Kuder, and K. Kiec-Kononowicz Fluorescent GPCR ligands as new tools in pharmacology Curr. Med. Chem. 15 2008 2132 2143
60. S.J. Briddon, and S.J. Hill Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand-receptor complexes Trends Pharmacol. Sci. 28 2007 637 645 (Pubitemid 350166574)
61. D. Jakobs, T. Sorkalla, and H. Haberlein Ligands for fluorescence correlation spectroscopy on g protein-coupled receptors Curr. Med. Chem. 19 2012 4722 4730
62. F.X. Ding, B.K. Lee, M. Hauser, R. Patri, B. Arshava, J.M. Becker, and F. Naider Study of the binding environment of α-factor in its G protein-coupled receptor using fluorescence spectroscopy J. Pept. Res. 60 2002 65 74 (Pubitemid 34680832)
63. C. Shi, Y.O. Shin, J. Hanson, B. Cass, M.C. Loewen, and Y. Durocher Purification and characterization of a recombinant G-protein-coupled receptor, Saccharomyces cerevisiae Ste2p, transiently expressed in HEK293 EBNA1 cells Biochemistry 44 2005 15705 15714 (Pubitemid 41746901)
64. F.X. Ding, B.K. Lee, M. Hauser, L. Davenport, J.M. Becker, and F. Naider Probing the binding domain of the Saccharomyces cerevisiae α-mating factor receptor with fluorescent ligands Biochemistry 40 2001 1102 1108 (Pubitemid 32108604)
65. M.R. Tota, and C.D. Strader Characterization of the binding domain of the beta-adrenergic receptor with the fluorescent antagonist carazolol. Evidence for a buried ligand binding site J. Biol. Chem. 265 1990 16891 16897
66. M.R. Tota, S. Daniel, A. Sirotina, K.E. Mazina, T.M. Fong, J. Longmore, and C.D. Strader Characterization of a fluorescent substance P analog Biochemistry 33 1994 13079 13086 (Pubitemid 24364755)
67. M.R. Tota, L. Xu, A. Sirotina, C.D. Strader, and M.P. Graziano Interaction of [fluorescein-Trp25] glucagon with the human glucagon receptor expressed in Drosophila Schneider 2 cells J. Biol. Chem. 270 1995 26466 26472 (Pubitemid 3006222)
68. L. Zemanova, A. Schenk, N. Hunt, G.U. Nienhaus, and R. Heilker Endothelin receptor in virus-like particles: ligand binding observed by fluorescence fluctuation spectroscopy Biochemistry 43 2004 9021 9028 (Pubitemid 38924436)
69. R.J. Middleton, S.J. Briddon, Y. Cordeaux, A.S. Yates, C.L. Dale, M.W. George, J.G. Baker, S.J. Hill, and B. Kellam New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells J. Med. Chem. 50 2007 782 793 (Pubitemid 46335649)
70. M. Rudiger, U. Haupts, K.J. Moore, and A.J. Pope Single-molecule detection technologies in miniaturized high throughput screening: binding assays for g protein-coupled receptors using fluorescence intensity distribution analysis and fluorescence anisotropy J. Biomol. Screen. 6 2001 29 37 (Pubitemid 32172442)
71. 2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy Biochemistry 46 2007 5106 5113 (Pubitemid 46683008)
72. S.J. Allen, S. Ribeiro, R. Horuk, and T.M. Handel Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1 Protein Expr. Purif. 66 2009 73 81
73. F. Junge, L.M. Luh, D. Proverbio, B. Schafer, R. Abele, M. Beyermann, V. Dotsch, and F. Bernhard Modulation of G-protein coupled receptor sample quality by modified cell-free expression protocols: a case study of the human endothelin A receptor J. Struct. Biol. 172 2010 94 106
74. P. Banks, M. Gosselin, and L. Prystay Fluorescence polarization assays for high throughput screening of G protein-coupled receptors J. Biomol. Screen. 5 2000 159 168
75. P. Banks, and M. Harvey Considerations for using fluorescence polarization in the screening of G protein-coupled receptors J. Biomol. Screen. 7 2002 111 117 (Pubitemid 34493709)
76. J.W. Jones, T.A. Greene, C.A. Grygon, B.J. Doranz, and M.P. Brown Cell-free assay of G-protein-coupled receptors using fluorescence polarization J. Biomol. Screen. 13 2008 424 429 (Pubitemid 351793990)
77. P.H. Lee, and D.J. Bevis Development of a homogeneous high throughput fluorescence polarization assay for G protein-coupled receptor binding J. Biomol. Screen. 5 2000 415 419 (Pubitemid 32107272)
78. K.G. Huwiler, T. De Rosier, B. Hanson, and K.W. Vogel A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor Assay Drug Dev. Technol. 8 2010 356 366
79. L. Prystay, M. Gosselin, and P. Banks Determination of equilibrium dissociation constants in fluorescence polarization J. Biomol. Screen. 6 2001 141 150 (Pubitemid 32554131)
80. L.A. Sklar, B.S. Edwards, S.W. Graves, J.P. Nolan, and E.R. Prossnitz Flow cytometric analysis of ligand-receptor interactions and molecular assemblies Annu. Rev. Biophys. Biomol. Struct. 31 2002 97 119 (Pubitemid 34666827)
81. L.A. Sklar Real-time spectroscopic analysis of ligand-receptor dynamics Annu. Rev. Biophys. Biophys. Chem. 16 1987 479 506
82. A. Bajaj, A. Celic, F.X. Ding, F. Naider, J.M. Becker, and M.E. Dumont A fluorescent α-factor analogue exhibits multiple steps on binding to its G protein coupled receptor in yeast Biochemistry 43 2004 13564 13578 (Pubitemid 39391157)
83. P.C. Simons, M. Shi, T. Foutz, D.F. Cimino, J. Lewis, T. Buranda, W.K. Lim, R.R. Neubig, W.E. McIntire, J. Garrison, E. Prossnitz, and L.A. Sklar Ligand-receptor-G-protein molecular assemblies on beads for mechanistic studies and screening by flow cytometry Mol. Pharmacol. 64 2003 1227 1238 (Pubitemid 37310755)
84. P.C. Simons, S.M. Biggs, A. Waller, T. Foutz, D.F. Cimino, Q. Guo, R.R. Neubig, W.J. Tang, E.R. Prossnitz, and L.A. Sklar Real-time analysis of ternary complex on particles: direct evidence for partial agonism at the agonist-receptor-G protein complex assembly step of signal transduction J. Biol. Chem. 279 2004 13514 13521 (Pubitemid 38468876)
85. E. Kozma, T.S. Kumar, S. Federico, K. Phan, R. Balasubramanian, Z.G. Gao, S. Paoletta, S. Moro, G. Spalluto, and K.A. Jacobson Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry Biochem. Pharmacol. 83 2012 1552 1561
86. E. Kozma, E.T. Gizewski, D.K. Tosh, L. Squarcialupi, J.A. Auchampach, and K.A. Jacobson Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor Biochem. Pharmacol. 85 2013 1171 1181
87. H. Heithier, D. Hallmann, F. Boege, H. Reilander, C. Dees, K.A. Jaeggi, D. Arndt-Jovin, T.M. Jovin, and E.J. Helmreich Synthesis and properties of fluorescent beta-adrenoceptor ligands Biochemistry 33 1994 9126 9134 (Pubitemid 24272863)
88. 2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure J. Mol. Biol. 376 2008 1305 1319
89. R.R. Petrov, M.E. Ferrini, Z. Jaffar, C.M. Thompson, K. Roberts, and P. Diaz Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells Bioorg. Med. Chem. Lett. 21 2011 5859 5862
90. S. Hatse, K. Princen, S. Liekens, K. Vermeire, E. De Clercq, and D. Schols Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies Cytometry A 61 2004 178 188 (Pubitemid 39362292)
91. A. Sachpatzidis, B.K. Benton, J.P. Manfredi, H. Wang, A. Hamilton, H.G. Dohlman, and E. Lolis Identification of allosteric peptide agonists of CXCR4 J. Biol. Chem. 278 2003 896 907 (Pubitemid 36790764)
92. S. Wang, A. Clemmons, C. Strader, and M. Bayne Evidence for hydrophobic interaction between galanin and the GalR1 galanin receptor and GalR1-mediated ligand internalization: fluorescent probing with a fluorescein-galanin Biochemistry 37 1998 9528 9535 (Pubitemid 28307709)
93. T. Hara, A. Hirasawa, Q. Sun, T.A. Koshimizu, C. Itsubo, K. Sadakane, T. Awaji, and G. Tsujimoto Flow cytometry-based binding assay for GPR40 (FFAR1; free fatty acid receptor 1) Mol. Pharmacol. 75 2009 85 91
94. E. Schneider, M. Keller, A. Brennauer, B.K. Hoefelschweiger, D. Gross, O.S. Wolfbeis, G. Bernhardt, and A. Buschauer Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist ChemBioChem 8 2007 1981 1988
95. A. Becker, C. Hessenius, S. Bhargava, C. Grotzinger, K. Licha, J. Schneider-Mergener, B. Wiedenmann, and W. Semmler Cyanine dye labeled vasoactive intestinal peptide and somatostatin analog for optical detection of gastroenteropancreatic tumors Ann. N. Y. Acad. Sci. 921 2000 275 278 (Pubitemid 32094553)
96. A. Becker, C. Hessenius, K. Licha, B. Ebert, U. Sukowski, W. Semmler, B. Wiedenmann, and C. Grotzinger Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands Nat. Biotechnol. 19 2001 327 331 (Pubitemid 32275340)
97. N.D. Doan, T.T. Nguyen, M. Letourneau, K. Turcotte, A. Fournier, and D. Chatenet Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart Br. J. Pharmacol. 166 2012 243 257
98. T. Durroux, M. Peter, G. Turcatti, A. Chollet, M.N. Balestre, C. Barberis, and R. Seyer Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications J. Med. Chem. 42 1999 1312 1319 (Pubitemid 29181153)
99. A. Bajaj, S.M. Connelly, A.U. Gehret, F. Naider, and M.E. Dumont Role of extracellular charged amino acids in the yeast α-factor receptor Biochim. Biophys. Acta 1773 2007 707 717 (Pubitemid 46829431)
100. E. Mathew, A. Bajaj, S.M. Connelly, H. Sargsyan, F.X. Ding, A.G. Hajduczok, F. Naider, and M.E. Dumont Differential interactions of fluorescent agonists and antagonists with the yeast G protein coupled receptor Ste2p J. Mol. Biol. 409 2011 513 528
101. S. Tantry, F.X. Ding, M. Dumont, J.M. Becker, and F. Naider Binding of fluorinated phenylalanine α-factor analogues to Ste2p: evidence for a cation-pi binding interaction between a peptide ligand and its cognate G protein-coupled receptor Biochemistry 49 2010 5007 5015
102. E. Mathew, F.X. Ding, F. Naider, and M.E. Dumont Functional fusions of T4 lysozyme in the third intracellular loop of a G protein-coupled receptor identified by a random screening approach in yeast Protein Eng. Des. Sel. 26 2013 59 71
103. M. Cottet, O. Faklaris, A. Falco, E. Trinquet, J.P. Pin, B. Mouillac, and T. Durroux Fluorescent ligands to investigate GPCR binding properties and oligomerization Biochem. Soc. Trans. 41 2013 148 153
104. D. Bonnet, B. Ilien, J.L. Galzi, S. Riche, C. Antheaune, and M. Hibert A rapid and versatile method to label receptor ligands using "click" chemistry: validation with the muscarinic M1 antagonist pirenzepine Bioconjug. Chem. 17 2006 1618 1623 (Pubitemid 44851510)
105. B. Ilien, C. Franchet, P. Bernard, S. Morisset, C.O. Weill, J.J. Bourguignon, M. Hibert, and J.L. Galzi Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties J. Neurochem. 85 2003 768 778 (Pubitemid 36531940)
106. C. Tahtaoui, F. Guillier, P. Klotz, J.L. Galzi, M. Hibert, and B. Ilien On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies J. Med. Chem. 48 2005 7847 7859 (Pubitemid 41698822)
107. S.B. Daval, C. Valant, D. Bonnet, E. Kellenberger, M. Hibert, J.L. Galzi, and B. Ilien Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors J. Med. Chem. 55 2012 2125 2143
108. M. Castro, V.O. Nikolaev, D. Palm, M.J. Lohse, and J.P. Vilardaga Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism Proc. Natl. Acad. Sci. U. S. A. 102 2005 16084 16089 (Pubitemid 41552871)
109. S. Lecat, B. Bucher, Y. Mely, and J.L. Galzi Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses J. Biol. Chem. 277 2002 42034 42048 (Pubitemid 35257518)
110. T. Palanche, B. Ilien, S. Zoffmann, M.P. Reck, B. Bucher, S.J. Edelstein, and J.L. Galzi The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states J. Biol. Chem. 276 2001 34853 34861
111. L. Albizu, G. Teppaz, R. Seyer, H. Bazin, H. Ansanay, M. Manning, B. Mouillac, and T. Durroux Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands J. Med. Chem. 50 2007 4976 4985 (Pubitemid 47527131)
112. K.G. Harikumar, D.I. Pinon, W.S. Wessels, E.S. Dawson, T.P. Lybrand, F.G. Prendergast, and L.J. Miller Measurement of intermolecular distances for the natural agonist peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer Mol. Pharmacol. 65 2004 28 35 (Pubitemid 38113883)
113. K.G. Harikumar, and L.J. Miller Fluorescence resonance energy transfer analysis of the antagonist- and partial agonist-occupied states of the cholecystokinin receptor J. Biol. Chem. 280 2005 18631 18635 (Pubitemid 41379562)
114. K.G. Harikumar, F. Gao, D.I. Pinon, and L.J. Miller Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor Biochemistry 47 2008 9574 9581
115. K.G. Harikumar, P.C. Lam, M. Dong, P.M. Sexton, R. Abagyan, and L.J. Miller Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues J. Biol. Chem. 282 2007 32834 32843 (Pubitemid 350159279)
116. G. Turcatti, K. Nemeth, M.D. Edgerton, U. Meseth, F. Talabot, M. Peitsch, J. Knowles, H. Vogel, and A. Chollet Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites J. Biol. Chem. 271 1996 19991 19998 (Pubitemid 26281747)
117. J.P. Leyris, T. Roux, E. Trinquet, P. Verdie, J.A. Fehrentz, N. Oueslati, S. Douzon, E. Bourrier, L. Lamarque, D. Gagne, J.C. Galleyrand, C. M'Kadmi, J. Martinez, S. Mary, J.L. Baneres, and J. Marie Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a Anal. Biochem. 408 2011 253 262
118. S. Loison, M. Cottet, H. Orcel, H. Adihou, R. Rahmeh, L. Lamarque, E. Trinquet, E. Kellenberger, M. Hibert, T. Durroux, B. Mouillac, and D. Bonnet Selective fluorescent nonpeptidic antagonists for vasopressin V(2) GPCR: application to ligand screening and oligomerization assays J. Med. Chem. 55 2012 8588 8602
119. J.M. Zwier, T. Roux, M. Cottet, T. Durroux, S. Douzon, S. Bdioui, N. Gregor, E. Bourrier, N. Oueslati, L. Nicolas, N. Tinel, C. Boisseau, P. Yverneau, F. Charrier-Savournin, M. Fink, and E. Trinquet A fluorescent ligand-binding alternative using Tag-lite(R) technology J. Biomol. Screen. 15 2010 1248 1259
120. 1-adrenergic G-protein-coupled receptor Nature 454 2008 486 491
121. G. Lebon, T. Warne, P.C. Edwards, K. Bennett, C.J. Langmead, A.G. Leslie, and C.G. Tate Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation Nature 474 2011 521 525
122. E. Chun, A.A. Thompson, W. Liu, C.B. Roth, M.T. Griffith, V. Katritch, J. Kunken, F. Xu, V. Cherezov, M.A. Hanson, and R.C. Stevens Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors Structure 20 2012 967 976
123. P.W. Day, S.G. Rasmussen, C. Parnot, J.J. Fung, A. Masood, T.S. Kobilka, X.J. Yao, H.J. Choi, W.I. Weis, D.K. Rohrer, and B.K. Kobilka A monoclonal antibody for G protein-coupled receptor crystallography Nat. Methods 4 2007 927 929 (Pubitemid 350042381)
124. 2-adrenergic G-protein-coupled receptor Nature 450 2007 383 387 (Pubitemid 350126755)
125. 2-adrenoceptor Nature 469 2011 175 180
126. C.A. Sarkar, I. Dodevski, M. Kenig, S. Dudli, A. Mohr, E. Hermans, and A. Pluckthun Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity Proc. Natl. Acad. Sci. U. S. A. 105 2008 14808 14813
127. K.M. Schlinkmann, M. Hillenbrand, A. Rittner, M. Kunz, R. Strohner, and A. Pluckthun Maximizing detergent stability and functional expression of a GPCR by exhaustive recombination and evolution J. Mol. Biol. 422 2012 414 428
128. K.M. Schlinkmann, A. Honegger, E. Tureci, K.E. Robison, D. Lipovsek, and A. Pluckthun Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations Proc. Natl. Acad. Sci. U. S. A. 109 2012 9810 9815
129. I. Dodevski, and A. Pluckthun Evolution of three human GPCRs for higher expression and stability J. Mol. Biol. 408 2011 599 615
130. D.J. Scott, and A. Plückthun Direct molecular evolution of detergent-stable g protein-coupled receptors using polymer encapsulated cells J. Mol. Biol. 425 2013 662 677
131. G. Turcatti, S. Zoffmann, J.A. Lowe 3rd, S.E. Drozda, G. Chassaing, T.W. Schwartz, and A. Chollet Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands J. Biol. Chem. 272 1997 21167 21175 (Pubitemid 27373977)
132. G. Turcatti, H. Vogel, and A. Chollet Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently Biochemistry 34 1995 3972 3980
133. K.G. Harikumar, D.I. Pinon, W.S. Wessels, F.G. Prendergast, and L.J. Miller Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor J. Biol. Chem. 277 2002 18552 18560 (Pubitemid 34952406)
134. K.G. Harikumar, J. Clain, D.I. Pinon, M. Dong, and L.J. Miller Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy J. Biol. Chem. 280 2005 1044 1050
135. K.G. Harikumar, K. Hosohata, D.I. Pinon, and L.J. Miller Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor J. Biol. Chem. 281 2006 2543 2550 (Pubitemid 43845714)
136. E. Eriotou-Bargiota, C.B. Xue, F. Naider, and J.M. Becker Antagonistic and synergistic peptide analogues of the tridecapeptide mating pheromone of Saccharomyces cerevisiae Biochemistry 31 1992 551 557
137. M.G. Abel, Y.L. Zhang, H.F. Lu, F. Naider, and J.M. Becker
138. F. Naider, and J.M. Becker The α-factor mating pheromone of Saccharomyces cerevisiae: a model for studying the interaction of peptide hormones and G protein-coupled receptors Peptides 25 2004 1441 1463 (Pubitemid 39221527)
139. S.A. Gai, and K.D. Wittrup Yeast surface display for protein engineering and characterization Curr. Opin. Struct. Biol. 17 2007 467 473 (Pubitemid 47454774)
140. K.D. Wittrup Protein engineering by cell-surface display Curr. Opin. Biotechnol. 12 2001 395 399 (Pubitemid 32718794)
141. J.P. Nolan, R.G. Posner, J.C. Martin, R. Habbersett, and L.A. Sklar A rapid mix flow cytometer with subsecond kinetic resolution Cytometry 21 1995 223 229
142. S.W. Graves, J.P. Nolan, J.H. Jett, J.C. Martin, and L.A. Sklar Nozzle design parameters and their effects on rapid sample delivery in flow cytometry Cytometry 47 2002 127 137 (Pubitemid 34117043)
143. G. Blankenstein, L.D. Scampavia, J. Ruzicka, and G.D. Christian Coaxial flow mixer for real-time monitoring of cellular responses in flow injection cytometry Cytometry 25 1996 200 204 (Pubitemid 26348912)
144. L.D. Scampavia, G. Blankenstein, J. Ruzicka, and G.D. Christian A coaxial jet mixer for rapid kinetic analysis in flow injection and flow injection cytometry Anal. Chem. 67 1995 2743 2749
145. J.P. Vilardaga, M. Bunemann, C. Krasel, M. Castro, and M.J. Lohse Measurement of the millisecond activation switch of G protein-coupled receptors in living cells Nat. Biotechnol. 21 2003 807 812 (Pubitemid 36791401)
146. T. Kenakin, and A. Christopoulos Signalling bias in new drug discovery: detection, quantification and therapeutic impact Nat. Rev. Drug Discov. 12 2013 205 216
147. B.K. Kobilka Structural insights into adrenergic receptor function and pharmacology Trends Pharmacol. Sci. 32 2011 213 218
148. M. Audet, and M. Bouvier Restructuring G-protein-coupled receptor activation Cell 151 2012 14 23
149. 2-adrenergic receptor-Gs protein complex Nature 477 2011 549 555
150. S.W. Lin, and T.P. Sakmar Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state Biochemistry 35 1996 11
151. J.L. Baneres, A. Martin, P. Hullot, J.P. Girard, J.C. Rossi, and J. Parello Structure-based analysis of GPCR function: conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombinant BLT1 J. Mol. Biol. 329 2003 801 814 (Pubitemid 36629372)
152. Y. Suzuki, E. Moriyoshi, D. Tsuchiya, and H. Jingami Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1 J. Biol. Chem. 279 2004 35526 35534 (Pubitemid 39100553)
153. K.H. Ruan, V. Cervantes, and J. Wu Ligand-specific conformation determines agonist activation and antagonist blockade in purified human thromboxane A2 receptor Biochemistry 48 2009 3157 3165
154. 2-adrenergic receptor. Evidence for ligand-specific conformational changes J. Biol. Chem. 270 1995 28268 28275
155. 2-adrenoceptor EMBO J. 16 1997 11
156. D.L. Farrens, C. Altenbach, K. Yang, W.L. Hubbell, and H.G. Khorana Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin Science 274 1996 768 770 (Pubitemid 26398253)
157. 2- adrenergic receptor J. Biol. Chem. 276 2001 24433 24436
158. 2-adrenergic receptor Proc. Natl. Acad. Sci. U. S. A. 98 2001 5997 6002 (Pubitemid 32488182)
159. L. Neumann, T. Wohland, R.J. Whelan, R.N. Zare, and B.K. Kobilka Functional immobilization of a ligand-activated G-protein-coupled receptor ChemBioChem 3 2002 993 998 (Pubitemid 35177752)
160. 2-adrenoceptor Nat. Chem. Biol. 2 2006 417 422 (Pubitemid 44114919)
161. 2-adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists J. Biol. Chem. 280 2005 22165 22171 (Pubitemid 40827872)
162. 2-adrenoceptor. Kinetic evidence for intermediate conformational states J. Biol. Chem. 279 2004 686 691 (Pubitemid 38044873)
163. J.F. Fay, and D.L. Farrens A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569 J. Biol. Chem. 287 2012 33873 33882
164. T.D. Dunham, and D.L. Farrens Conformational changes in rhodopsin. Movement of helix f detected by site-specific chemical labeling and fluorescence spectroscopy J. Biol. Chem. 274 1999 1683 1690
165. J.M. Janz, and D.L. Farrens Rhodopsin activation exposes a key hydrophobic binding site for the transducin α-subunit C terminus J. Biol. Chem. 279 2004 29767 29773 (Pubitemid 38915860)
166. T.Y. Kim, T. Schlieter, S. Haase, and U. Alexiev Activation and molecular recognition of the GPCR rhodopsin - insights from time-resolved fluorescence depolarisation and single molecule experiments Eur. J. Cell Biol. 91 2011 300 310
167. S. Mary, M. Damian, M. Louet, N. Floquet, J.A. Fehrentz, J. Marie, J. Martinez, and J.L. Baneres Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor Proc. Natl. Acad. Sci. U. S. A. 109 2012 8304 8309
168. M.J. Lohse, V.O. Nikolaev, P. Hein, C. Hoffmann, J.P. Vilardaga, and M. Bunemann Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors Trends Pharmacol. Sci. 29 2008 159 165
169. C. Hoffmann, G. Gaietta, M. Bunemann, S.R. Adams, S. Oberdorff-Maass, B. Behr, J.P. Vilardaga, R.Y. Tsien, M.H. Ellisman, and M.J. Lohse A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells Nat. Methods 2 2005 171 176 (Pubitemid 41122123)
170. J.B. Jensen, J.S. Lyssand, C. Hague, and B. Hille Fluorescence changes reveal kinetic steps of muscarinic receptor-mediated modulation of phosphoinositides and Kv7.2/7.3 K + channels J. Gen. Physiol. 133 2009 347 359
171. S. Chang, and E.M. Ross Activation biosensor for G protein-coupled receptors: a FRET-based m1 muscarinic activation sensor that regulates G(q) PLoS One 7 2012 e45651
172. A.U. Gehret, A. Bajaj, F. Naider, and M.E. Dumont Oligomerization of the yeast α-factor receptor: implications for dominant negative effects of mutant receptors J. Biol. Chem. 281 2006 20698 20714 (Pubitemid 44115412)
173. B.A. Griffin, S.R. Adams, and R.Y. Tsien Specific covalent labeling of recombinant protein molecules inside live cells Science 281 1998 269 272 (Pubitemid 28334512)
174. 2 +-dye label reveals STIM1 surface exposure Proc. Natl. Acad. Sci. U. S. A. 104 2007 3693 3697 (Pubitemid 47181517)
175. D. Maurel, L. Comps-Agrar, C. Brock, M.L. Rives, E. Bourrier, M.A. Ayoub, H. Bazin, N. Tinel, T. Durroux, L. Prezeau, E. Trinquet, and J.P. Pin Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization Nat. Methods 5 2008 561 567 (Pubitemid 351761765)
176. M. Fernandez-Suarez, and A.Y. Ting Fluorescent probes for super-resolution imaging in living cells Nat. Rev. Mol. Cell Biol. 9 2008 929 943
177. 2-adrenoceptor: insights from fluorescence resonance energy transfer studies J. Biol. Chem. 282 2007 13895 13905 (Pubitemid 47100565)
178. 2-adrenergic receptor in living cells Biochem. Biophys. Res. Commun. 343 2006 1191 1196
179. K.Y. Chung, T.H. Kim, A. Manglik, R. Alvares, B.K. Kobilka, and R.S. Prosser Role of detergents in conformational exchange of a G protein-coupled receptor J. Biol. Chem. 287 2012 36305 36311
180. 2-adrenergic receptor J. Biol. Chem. 285 2010 36188 36198
181. M.J. Lohse, J.P. Vilardaga, and M. Bunemann Direct optical recording of intrinsic efficacy at a G protein-coupled receptor Life Sci. 74 2003 397 404 (Pubitemid 37357069)
182. J.-P. Vilardaga, R. Steinmeyer, G.S. Harms, and M.J. Lohse Molecular basis of inverse agonism in a G protein-coupled receptor Nat. Chem. Biol. 1 2005 4
183. 2A- adrenergic receptor and Gi-protein heterotrimer J. Biol. Chem. 281 2006 24506 24511 (Pubitemid 44274225)
184. M. Ambrosio, and M.J. Lohse Nonequilibrium activation of a G-protein-coupled receptor Mol. Pharmacol. 81 2012 770 777
185. M. Maier-Peuschel, N. Frolich, C. Dees, L.G. Hommers, C. Hoffmann, V.O. Nikolaev, and M.J. Lohse A fluorescence resonance energy transfer-based M2 muscarinic receptor sensor reveals rapid kinetics of allosteric modulation J. Biol. Chem. 285 2010 8793 8800
186. N. Ziegler, J. Batz, U. Zabel, M.J. Lohse, and C. Hoffmann FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors Bioorg. Med. Chem. 19 2011 1048 1054
187. D. Markovic, J. Holdich, S. Al-Sabah, R. Mistry, C. Krasel, M.P. Mahaut-Smith, and R.A. Challiss FRET-based detection of M1 muscarinic acetylcholine receptor activation by orthosteric and allosteric agonists PLoS One 7 2012 e29946
188. C. Hoffmann, S. Nuber, U. Zabel, N. Ziegler, C. Winkler, P. Hein, C.H. Berlot, M. Bunemann, and M.J. Lohse Comparison of the activation kinetics of the M3 acetylcholine receptor and a constitutively active mutant receptor in living cells Mol. Pharmacol. 82 2012 236 245
189. M. Chachisvilis, Y.L. Zhang, and J.A. Frangos G protein-coupled receptors sense fluid shear stress in endothelial cells Proc. Natl. Acad. Sci. U. S. A. 103 2006 15463 15468 (Pubitemid 44625614)
190. D. Calebiro, F. Rieken, J. Wagner, T. Sungkaworn, U. Zabel, A. Borzi, E. Cocucci, A. Zurn, and M.J. Lohse Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization Proc. Natl. Acad. Sci. U. S. A. 110 2013 743 748
191. R.S. Kasai, K.G. Suzuki, E.R. Prossnitz, I. Koyama-Honda, C. Nakada, T.K. Fujiwara, and A. Kusumi Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging J. Cell Biol. 192 2011 463 480
192. Y. Lill, K.L. Martinez, M.A. Lill, B.H. Meyer, H. Vogel, and B. Hecht Kinetics of the initial steps of G protein-coupled receptor-mediated cellular signaling revealed by single-molecule imaging Chemphyschem 6 2005 1633 1640 (Pubitemid 41187248)
193. M. Ueda, Y. Sako, T. Tanaka, P. Devreotes, and T. Yanagida Single-molecule analysis of chemotactic signaling in Dictyostelium cells Science 294 2001 864 867 (Pubitemid 33032106)
194. J.A. Hern, A.H. Baig, G.I. Mashanov, B. Birdsall, J.E. Corrie, S. Lazareno, J.E. Molloy, and N.J. Birdsall Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules Proc. Natl. Acad. Sci. U. S. A. 107 2010 2693 2698
195. T. Huber, and T.P. Sakmar Escaping the flatlands: new approaches for studying the dynamic assembly and activation of GPCR signaling complexes Trends Pharmacol. Sci. 32 2011 410 419
196. J.F. Lesoine, P.A. Venkataraman, P.C. Maloney, M.E. Dumont, and L. Novotny Nanochannel-based single molecule recycling Nano Lett. 12 2012 3273 3278
197. 2-adrenergic receptor: observation of conformational substates in a membrane protein Proc. Natl. Acad. Sci. U. S. A. 98 2001 8469 8474 (Pubitemid 32678051)
198. S. Bockenhauer, A. Fürstenberg, X.J. Yao, B.K. Kobilka, and W.E. Moerner Conformational dynamics of single G protein-coupled receptors in solution J. Phys. Chem. B 115 2011 11
199. K. Aslan, I. Gryczynski, J. Malicka, E. Matveeva, J.R. Lakowicz, and C.D. Geddes Metal-enhanced fluorescence: an emerging tool in biotechnology Curr. Opin. Biotechnol. 16 2005 55 62 (Pubitemid 40253579)
200. C. Hoppener, and L. Novotny Exploiting the light-metal interaction for biomolecular sensing and imaging Q. Rev. Biophys. 45 2012 209 255
201. D. Toomre, and J. Bewersdorf A new wave of cellular imaging Annu. Rev. Cell Dev. Biol. 26 2010 285 314
202. M. Howarth, K. Takao, Y. Hayashi, and A.Y. Ting Targeting quantum dots to surface proteins in living cells with biotin ligase Proc. Natl. Acad. Sci. U. S. A. 102 2005 7583 7588 (Pubitemid 40741014)
203. M. Zhou, E. Nakatani, L.S. Gronenberg, T. Tokimoto, M.J. Wirth, V.J. Hruby, A. Roberts, R.M. Lynch, and I. Ghosh Peptide-labeled quantum dots for imaging GPCRs in whole cells and as single molecules Bioconjug. Chem. 18 2007 323 332 (Pubitemid 46493502)
204. C.J. Daly, C.M. Milligan, G. Milligan, J.F. Mackenzie, and J.C. McGrath Cellular localization and pharmacological characterization of functioning α-1 adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors J. Pharmacol. Exp. Ther. 286 1998 984 990 (Pubitemid 29003494)
205. 1-adrenoceptor subtypes can affect the subtype selectivity of drugs in a study with the fluorescent ligand BODIPY FL-prazosin Life Sci. 70 2002 2113 2124 (Pubitemid 34219462)
206. F.M. Correa, R.B. Innis, B. Rouot, G.W. Pasternak, and S.H. Snyder Fluorescent probes of α- and β-adrenergic and opiate receptors: biochemical and histochemical evaluation Neurosci. Lett. 16 1980 47 53 (Pubitemid 10125752)
207. 1-adrenoceptors in native smooth muscle cells J. Auton. Pharmacol. 19 1999 303 310 (Pubitemid 30616151)
208. 1- adrenoceptor ligand-binding sites J. Pharmacol. Exp. Ther. 294 2000 434 443 (Pubitemid 30490813)
209. 2-adrenoceptor Br. J. Pharmacol. 137 2002 400 408
210. 2- adrenoceptor agonist Br. J. Pharmacol. 139 2003 232 242 (Pubitemid 36760355)
211. H. Heithier, K.A. Jaeggi, L.D. Ward, R.C. Cantrill, and E.J. Helmreich Synthesis and characterization of CGP-12177-NBD: a fluorescent beta-adrenergic receptor probe Biochimie 70 1988 687 694
212. D. Atlas, and A. Levitzki Fluorescent visualization of beta-adrenergic receptors on cell surfaces FEBS Lett. 85 1978 158 162 (Pubitemid 8252915)
213. J.G. Baker, L.A. Adams, K. Salchow, S.N. Mistry, R.J. Middleton, S.J. Hill, and B. Kellam Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human beta-adrenoceptors J. Med. Chem. 54 2011 6874 6887
214. 2-adrenergic receptor-ligand complexes on living cells Biochemistry 43 2004 6190 6199 (Pubitemid 38669487)
215. E. Melamed, M. Luhar, and D. Atlas Histochemical labeling of beta-adrenergic receptors in the mouse central nervous system by 9-amino-acridin propranolol Neurology 28 1978 850 853 (Pubitemid 8382994)
216. D. Atlas, and E. Melamed Direct mapping of beta-adrenergic receptors in the rat central nervous system by a novel fluorescent beta-blocker Brain Res. 150 1978 377 385 (Pubitemid 8374929)
217. M. Lahav, E. Melamed, Z. Dafna, and D. Atlas Localization of beta receptors in the anterior segment of the rat eye by a fluorescent analogue of propranolol Invest. Ophthalmol. Vis. Sci. 17 1978 645 651 (Pubitemid 8364260)
218. Y.I. Henis, M. Hekman, E.L. Elson, and E.J. Helmreich Lateral motion of beta receptors in membranes of cultured liver cells Proc. Natl. Acad. Sci. U. S. A. 79 1982 2907 2911 (Pubitemid 12032341)
219. B. Rademaker, K. Kramer, A. Bast, and H. Timmerman Irreversible binding of the fluorescent beta-adrenoceptor probes alprenolol-NBD and pindolol-NBD to specific and non-specific binding sites Res. Commun. Chem. Pathol. Pharmacol. 60 1988 147 159
220. J.G. Baker, R. Middleton, L. Adams, L.T. May, S.J. Briddon, B. Kellam, and S.J. Hill Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands Br. J. Pharmacol. 159 2010 772 786
221. L.T. May, L.J. Bridge, L.A. Stoddart, S.J. Briddon, and S.J. Hill Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics FASEB J. 25 2011 3465 3476
222. L.A. Stoddart, A.J. Vernall, J.L. Denman, S.J. Briddon, B. Kellam, and S.J. Hill Fragment screening at adenosine-A(3) receptors in living cells using a fluorescence-based binding assay Chem. Biol. 19 2012 1105 1115
223. A.J. Vernall, L.A. Stoddart, S.J. Briddon, S.J. Hill, and B. Kellam Highly potent and selective fluorescent antagonists of the human adenosine A(3) receptor based on the 1,2,4-triazolo[4,3-a] quinoxalin-1-one scaffold J. Med. Chem. 55 2012 1771 1782
224. D.K. Tosh, F. Deflorian, K. Phan, Z.G. Gao, T.C. Wan, E. Gizewski, J.A. Auchampach, and K.A. Jacobson Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0] hexane substitutions J. Med. Chem. 55 2012 4847 4860
225. L.T. May, T.J. Self, S.J. Briddon, and S.J. Hill The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells Mol. Pharmacol. 78 2010 511 523
226. F. Brand, A.M. Klutz, K.A. Jacobson, B.B. Fredholm, and G. Schulte Adenosine A(2A) receptor dynamics studied with the novel fluorescent agonist Alexa488-APEC Eur. J. Pharmacol. 590 2008 36 42
227. S.J. Briddon, R.J. Middleton, Y. Cordeaux, F.M. Flavin, J.A. Weinstein, M.W. George, B. Kellam, and S.J. Hill Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 4673 4678 (Pubitemid 38437469)
228. Y. Cordeaux, S.J. Briddon, S.P. Alexander, B. Kellam, and S.J. Hill Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells FASEB J. 22 2008 850 860 (Pubitemid 351350620)
229. S.J. Briddon, R.J. Middleton, A.S. Yates, M.W. George, B. Kellam, and S.J. Hill Application of fluorescence correlation spectroscopy to the measurement of agonist binding to a G-protein coupled receptor at the single cell level Faraday Discuss. 126 2004 197 207 (discussion 245-154) (Pubitemid 38372082)
230. T.S. Kumar, S. Mishra, F. Deflorian, L.S. Yoo, K. Phan, M. Kecskes, A. Szabo, B. Shinkre, Z.G. Gao, W. Trenkle, and K.A. Jacobson Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e] [1,2,4] triazolo[1,5-c] pyrimidin-5-amine scaffold Bioorg. Med. Chem. Lett. 21 2011 2740 2745
231. M. Macchia, S. Bertini, V. Di Bussolo, C. Manera, C. Martini, F. Minutolo, C. Mori, G. Saccomanni, D. Tuscano, and P.L. Ferrarini 4-[6-(Dansylamino)hexylamino]-7-methyl-2-phenyl-1,8-naphthyridine as a new potential fluorescent probe for studying A1-adenosine receptor Farmaco 57 2002 783 786 (Pubitemid 35440973)
232. M. Macchia, F. Salvetti, S. Bertini, V. Di Bussolo, L. Gattuso, M. Gesi, M. Hamdan, K.N. Klotz, T. Laragione, A. Lucacchini, F. Minutolo, S. Nencetti, C. Papi, D. Tuscano, and C. Martini 7-Nitrobenzofurazan (NBD) derivatives of 5′-N-ethylcarboxamidoadenosine (NECA) as new fluorescent probes for human A(3) adenosine receptors Bioorg. Med. Chem. Lett. 11 2001 3023 3026 (Pubitemid 33063621)
233. A. Falleni, M.L. Trincavelli, M. Macchia, F. Salvetti, M. Hamdan, F. Calvani, V. Gremigni, A. Lucacchini, and C. Martini A(1) adenosine receptors in human neutrophils: direct binding and electron microscope visualization J. Cell. Biochem. 75 1999 235 244 (Pubitemid 29463492)
234. M. Macchia, F. Salvetti, S. Barontini, F. Calvani, M. Gesi, M. Hamdan, A. Lucacchini, A. Pellegrini, P. Soldani, and C. Martini Fluorescent probes for adenosine receptors: synthesis and biology of N6-dansylaminoalkyl-substituted NECA derivatives Bioorg. Med. Chem. Lett. 8 1998 3223 3228 (Pubitemid 28551651)
235. E. Kozma, P.S. Jayasekara, L. Squarcialupi, S. Paoletta, S. Moro, S. Federico, G. Spalluto, and K.A. Jacobson Fluorescent ligands for adenosine receptors Bioorg. Med. Chem. Lett. 23 2013 26 36
236. L. Hunyady, A.J. Baukal, Z. Gaborik, J.A. Olivares-Reyes, M. Bor, M. Szaszak, R. Lodge, K.J. Catt, and T. Balla Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor J. Cell Biol. 157 2002 1211 1222 (Pubitemid 34847791)
237. O. von Bohlen und Halbach, and D. Albrecht Distribution of angiotensin II binding sites in the mouse thalamus: receptor-binding study with fluorescent coupled peptides and their conversion to a light stable product Neuropeptides 33 1999 464 467 (Pubitemid 30110876)
238. X. Iturrioz, R. Alvear-Perez, N. De Mota, C. Franchet, F. Guillier, V. Leroux, H. Dabire, M. Le Jouan, H. Chabane, R. Gerbier, D. Bonnet, A. Berdeaux, B. Maigret, J.L. Galzi, M. Hibert, and C. Llorens-Cortes Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist FASEB J. 24 2010 1506 1517
239. L. Gera, C. Roy, M.T. Bawolak, X. Charest-Morin, and F. Marceau N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes Peptides 34 2012 433 446
240. M. Sexton, G. Woodruff, E.A. Horne, Y.H. Lin, G.G. Muccioli, M. Bai, E. Stern, D.J. Bornhop, and N. Stella NIR-mbc94, a fluorescent ligand that binds to endogenous CB(2) receptors and is amenable to high-throughput screening Chem. Biol. 18 2011 563 568
241. A.S. Yates, S.W. Doughty, D.A. Kendall, and B. Kellam Chemical modification of the naphthoyl 3-position of JWH-015: in search of a fluorescent probe to the cannabinoid CB2 receptor Bioorg. Med. Chem. Lett. 15 2005 3758 3762 (Pubitemid 41038973)
242. M. Bai, M. Sexton, N. Stella, and D.J. Bornhop MBC94, a conjugable ligand for cannabinoid CB 2 receptor imaging Bioconjug. Chem. 19 2008 988 992 (Pubitemid 351748305)
243. R. Masuda, S. Oishi, N. Tanahara, H. Ohno, A. Hirasawa, G. Tsujimoto, E. Kodama, M. Matsuoka, and N. Fujii Development and application of fluorescent SDF-1 derivatives Future Med. Chem. 4 2012 837 844
244. J.C. Knight, A.J. Hallett, A. Brancale, S.J. Paisey, R.W. Clarkson, and P.G. Edwards Evaluation of a fluorescent derivative of AMD3100 and its interaction with the CXCR4 chemokine receptor ChemBioChem 12 2011 2692 2698
245. A.E. Strong, A.C. Thierry, P. Cousin, C. Moulon, and S. Demotz Synthetic chemokines directly labeled with a fluorescent dye as tools for studying chemokine and chemokine receptor interactions Eur. Cytokine Netw. 17 2006 49 59
246. W. Nomura, Y. Tanabe, H. Tsutsumi, T. Tanaka, K. Ohba, N. Yamamoto, and H. Tamamura Fluorophore labeling enables imaging and evaluation of specific CXCR4-ligand interaction at the cell membrane for fluorescence-based screening Bioconjug. Chem. 19 2008 1917 1920
247. K.G. Harikumar, E.E. Cawston, and L.J. Miller Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor Assay Drug Dev. Technol. 9 2011 394 402
248. K.G. Harikumar, and L.J. Miller Applications of fluorescence in the characterization of the ligand-binding domain and activation of the cholecystokinin receptor Pharmacol. Toxicol. 91 2002 286 289 (Pubitemid 36132432)
249. A. Sturzu, S. Sheikh, U. Klose, M. Deeg, H. Echner, T. Nagele, U. Ernemann, and S. Heckl Novel gastrin receptor-directed contrast agents - potential in brain tumor magnetic resonance imaging Med. Chem. 8 2012 133 137
250. S. Kumari, J. Chowdhury, A.K. Mishra, S. Chandna, D. Saluja, and M. Chopra Synthesis and evaluation of a fluorescent non-peptidic cholecystokinin-B/gastrin receptor specific antagonist for cancer cell imaging ChemBioChem 13 2012 282 292
251. M. Leopoldo, E. Lacivita, E. Passafiume, M. Contino, N.A. Colabufo, F. Berardi, and R. Perrone 4-[omega-[4-arylpiperazin-1-yl] alkoxy] phenyl)imidazo[1,2-a] pyridine derivatives: fluorescent high-affinity dopamine D3 receptor ligands as potential probes for receptor visualization J. Med. Chem. 50 2007 5043 5047 (Pubitemid 47525485)
252. C. Caballero-George, T. Sorkalla, D. Jakobs, J. Bolanos, H. Raja, C. Shearer, E. Bermingham, and H. Haberlein Fluorescence correlation spectroscopy in drug discovery: study of Alexa532-endothelin 1 binding to the endothelin ETA receptor to describe the pharmacological profile of natural products ScientificWorldJournal 2012 2012 524169
253. C. Holtke, A. von Wallbrunn, K. Kopka, O. Schober, W. Heindel, M. Schafers, and C. Bremer A fluorescent photoprobe for the imaging of endothelin receptors Bioconjug. Chem. 18 2007 685 694 (Pubitemid 47010787)
254. J.F. Hoffman, J.J. Linderman, and G.M. Omann Receptor up-regulation, internalization, and interconverting receptor states. Critical components of a quantitative description of N-formyl peptide-receptor dynamics in the neutrophil J. Biol. Chem. 271 1996 18394 18404 (Pubitemid 26322695)
255. L.A. Sklar, H. Mueller, G. Omann, and Z. Oades Three states for the formyl peptide receptor on intact cells J. Biol. Chem. 264 1989 8483 8486 (Pubitemid 19151557)
256. L.A. Sklar, G.M. Bokoch, D. Button, and J.E. Smolen Regulation of ligand-receptor dynamics by guanine nucleotides. Real-time analysis of interconverting states for the neutrophil formyl peptide receptor J. Biol. Chem. 262 1987 135 139 (Pubitemid 17235643)
257. L.A. Sklar, G.M. Bokoch, W.N. Swann, C. Comstock, and J.E. Smolen Ligand-receptor dynamics and signal amplification in the neutrophil Int. J. Tissue React. 9 1987 277 284 (Pubitemid 17112040)
258. L.A. Sklar, S.P. Fay, B.E. Seligmann, R.J. Freer, N. Muthukumaraswamy, and H. Mueller Fluorescence analysis of the size of a binding pocket of a peptide receptor at natural abundance Biochemistry 29 1990 313 316 (Pubitemid 20037634)
259. S.P. Fay, M.D. Domalewski, and L.A. Sklar Evidence for protonation in the human neutrophil formyl peptide receptor binding pocket Biochemistry 32 1993 1627 1631 (Pubitemid 23077572)
260. S.P. Fay, R.G. Posner, W.N. Swann, and L.A. Sklar Real-time analysis of the assembly of ligand, receptor, and G protein by quantitative fluorescence flow cytometry Biochemistry 30 1991 5066 5075
261. J.B. Arterburn, T.I. Oprea, E.R. Prossnitz, B.S. Edwards, and L.A. Sklar Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30 Curr. Top. Med. Chem. 9 2009 1227 1236
262. i2 fusion protein: assemblies with G proteins and arrestins Biochemistry 42 2003 7283 7293 (Pubitemid 36735807)
263. A. Pramanik, M. Olsson, U. Langel, T. Bartfai, and R. Rigler Fluorescence correlation spectroscopy detects galanin receptor diversity on insulinoma cells Biochemistry 40 2001 10839 10845 (Pubitemid 32842449)
264. L.D. Ward, R.C. Cantrill, H. Heithier, R. Peters, and E.J. Helmreich Fluorescent glucagon derivatives. II. The use of fluorescent glucagon derivatives for the study of receptor disposition in membranes Biochim. Biophys. Acta 971 1988 307 316
265. H. Heithier, L.D. Ward, R.C. Cantrill, H.W. Klein, M.J. Im, G. Pollak, B. Freeman, E. Schiltz, R. Peters, and E.J. Helmreich Fluorescent glucagon derivatives. I. Synthesis and characterisation of fluorescent glucagon derivatives Biochim. Biophys. Acta 971 1988 298 306
266. R. McGirr, M.S. McFarland, J. McTavish, L.G. Luyt, and S. Dhanvantari Design and characterization of a fluorescent ghrelin analog for imaging the growth hormone secretagogue receptor 1a Regul. Pept. 172 2011 69 76
267. R.H. Rose, S.J. Briddon, and S.J. Hill A novel fluorescent histamine H(1) receptor antagonist demonstrates the advantage of using fluorescence correlation spectroscopy to study the binding of lipophilic ligands Br. J. Pharmacol. 165 2012 1789 1800
268. K.J. Kuder, T. Kottke, H. Stark, X. Ligneau, J.C. Camelin, R. Seifert, and K. Kiec-Kononowicz Search for novel, high affinity histamine H3 receptor ligands with fluorescent properties Inflamm. Res. 59 Suppl. 2 2010 S247 S248
269. S.F. Malan, A. van Marle, W.M. Menge, V. Zuliani, M. Hoffman, H. Timmerman, and R. Leurs Fluorescent ligands for the histamine H2 receptor: synthesis and preliminary characterization Bioorg. Med. Chem. 12 2004 6495 6503 (Pubitemid 39535172)
270. L. Li, J. Kracht, S. Peng, G. Bernhardt, and A. Buschauer Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine Bioorg. Med. Chem. Lett. 13 2003 1245 1248 (Pubitemid 36351326)
271. L. Li, J. Kracht, S. Peng, G. Bernhardt, S. Elz, and A. Buschauer Synthesis and pharmacological activity of fluorescent histamine H2 receptor antagonists related to potentidine Bioorg. Med. Chem. Lett. 13 2003 1717 1720 (Pubitemid 36561149)
272. M. Cowart, G.A. Gfesser, K. Bhatia, R. Esser, M. Sun, T.R. Miller, K. Krueger, D. Witte, T.A. Esbenshade, and A.A. Hancock Fluorescent benzofuran histamine H(3) receptor antagonists with sub-nanomolar potency Inflamm. Res. 55 Suppl. 1 2006 S47 S48
273. M. Amon, X. Ligneau, J.C. Camelin, I. Berrebi-Bertrand, J.C. Schwartz, and H. Stark Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands ChemMedChem 2 2007 708 716
274. M. Amon, X. Ligneau, J.C. Schwartz, and H. Stark Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities Bioorg. Med. Chem. Lett. 16 2006 1938 1940 (Pubitemid 43267381)
275. K. Isensee, M. Amon, A. Garlapati, X. Ligneau, J.C. Camelin, M. Capet, J.C. Schwartz, and H. Stark Fluorinated non-imidazole histamine H3 receptor antagonists Bioorg. Med. Chem. Lett. 19 2009 2172 2175
276. S.X. Xie, G. Petrache, E. Schneider, Q.Z. Ye, G. Bernhardt, R. Seifert, and A. Buschauer Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine Bioorg. Med. Chem. Lett. 16 2006 3886 3890 (Pubitemid 43903233)
277. A. Sabirsh, A. Wetterholm, J. Bristulf, H. Leffler, J.Z. Haeggstrom, and C. Owman Fluorescent leukotriene B4: potential applications J. Lipid Res. 46 2005 1339 1346
278. R.M. Fernandez, A.S. Ito, H.B. Schioth, and M.T. Lamy Structural study of melanocortin peptides by fluorescence spectroscopy: identification of beta-(2-naphthyl)-D-alanine as a fluorescent probe Biochim. Biophys. Acta 1623 2003 13 20 (Pubitemid 37088053)
279. M. Cai, M. Stankova, S.J. Pond, A.V. Mayorov, J.W. Perry, H.I. Yamamura, D. Trivedi, and V.J. Hruby Real time differentiation of G-protein coupled receptor (GPCR) agonist and antagonist by two photon fluorescence laser microscopy J. Am. Chem. Soc. 126 2004 7160 7161 (Pubitemid 38747750)
280. C. Tahtaoui, I. Parrot, P. Klotz, F. Guillier, J.L. Galzi, M. Hibert, and B. Ilien Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor J. Med. Chem. 47 2004 4300 4315 (Pubitemid 39045436)
281. P.H. Lee, S.C. Miller, C. van Staden, and E.F. Cromwell Development of a homogeneous high-throughput live-cell G-protein-coupled receptor binding assay J. Biomol. Screen. 13 2008 748 754
282. B. Ilien, N. Glasser, J.P. Clamme, P. Didier, E. Piemont, R. Chinnappan, S.B. Daval, J.L. Galzi, and Y. Mely Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process J. Biol. Chem. 284 2009 19533 19543
283. M. Fabry, M. Langer, B. Rothen-Rutishauser, H. Wunderli-Allenspach, H. Hocker, and A.G. Beck-Sickinger Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC Eur. J. Biochem. 267 2000 5631 5637
284. Y. Dumont, P. Gaudreau, M. Mazzuferi, D. Langlois, J.G. Chabot, A. Fournier, M. Simonato, and R. Quirion BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes Br. J. Pharmacol. 146 2005 1069 1081 (Pubitemid 41785319)
285. R. Ziemek, E. Schneider, A. Kraus, C. Cabrele, A.G. Beck-Sickinger, G. Bernhardt, and A. Buschauer Determination of affinity and activity of ligands at the human neuropeptide Y Y4 receptor by flow cytometry and aequorin luminescence J. Recept. Signal Transduct. Res. 27 2007 217 233 (Pubitemid 47450772)
286. R. Ziemek, A. Brennauer, E. Schneider, C. Cabrele, A.G. Beck-Sickinger, G. Bernhardt, and A. Buschauer Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands Eur. J. Pharmacol. 551 2006 10 18 (Pubitemid 44648057)
287. L. Li, M. Mayer, E. Schneider, E. Schreiber, G. Bernhardt, S. Peng, and A. Buschauer Preparation of fluorescent nonpeptidic neuropeptide Y receptor ligands: analogues of the quinazoline-type anti-obesity Y5 antagonist CGP 71683A Arch. Pharm. (Weinheim) 336 2003 585 590 (Pubitemid 38076214)
288. L.E. Kilpatrick, S.J. Briddon, and N.D. Holliday Fluorescence correlation spectroscopy, combined with bimolecular fluorescence complementation, reveals the effects of beta-arrestin complexes and endocytic targeting on the membrane mobility of neuropeptide Y receptors Biochim. Biophys. Acta 1823 2012 1068 1081
289. M. Fabry, C. Cabrele, H. Hocker, and A.G. Beck-Sickinger Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line Peptides 21 2000 1885 1893 (Pubitemid 32058864)
290. A. Beaudet, D. Nouel, T. Stroh, F. Vandenbulcke, C. Dal-Farra, and J.P. Vincent Fluorescent ligands for studying neuropeptide receptors by confocal microscopy Braz. J. Med. Biol. Res. 31 1998 1479 1489 (Pubitemid 128528301)
291. P. Sarret, L. Gendron, P. Kilian, H.M. Nguyen, N. Gallo-Payet, M.D. Payet, and A. Beaudet Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells J. Biol. Chem. 277 2002 36233 36243
292. S. Arttamangkul, V. Alvarez-Maubecin, G. Thomas, J.T. Williams, and D.K. Grandy Binding and internalization of fluorescent opioid peptide conjugates in living cells Mol. Pharmacol. 58 2000 1570 1580
293. S.G. Rasmussen, F.I. Carroll, M.J. Maresch, A.D. Jensen, C.G. Tate, and U. Gether Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporter J. Biol. Chem. 276 2001 4717 4723
294. P.J. Emmerson, S. Archer, W. El-Hamouly, A. Mansour, H. Akil, and F. Medzihradsky Synthesis and characterization of 4,4-difluoro-4-bora-3a,4a-diaza- s-indacene (BODIPY)-labeled fluorescent ligands for the mu opioid receptor Biochem. Pharmacol. 54 1997 1315 1322 (Pubitemid 27521042)
295. B.W. Madsen, C.L. Beglan, and C.E. Spivak Fluorescein-labeled naloxone binding to mu opioid receptors on live Chinese hamster ovary cells using confocal fluorescent microscopy J. Neurosci. Methods 97 2000 123 131 (Pubitemid 30219453)
296. P.W. Schiller, I. Berezowska, G. Weltrowska, H. Chen, C. Lemieux, and N.N. Chung Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt] DALDA affect potency, receptor selectivity and intrinsic efficacy J. Pept. Res. 65 2005 556 563 (Pubitemid 40776408)
297. I. Berezowska, C. Lemieux, N.N. Chung, B. Zelent, and P.W. Schiller Dansylated analogues of the opioid peptide [Dmt1] DALDA: in vitro activity profiles and fluorescence parameters Acta Biochim. Pol. 51 2004 107 113 (Pubitemid 38608807)
298. I. Berezowska, N.N. Chung, C. Lemieux, B. Zelent, H.H. Szeto, and P.W. Schiller Highly potent fluorescent analogues of the opioid peptide [Dmt1] DALDA Peptides 24 2003 1195 1200 (Pubitemid 37386307)
299. J.L. Swift, M.C. Burger, D. Massotte, T.E. Dahms, and D.T. Cramb Two-photon excitation fluorescence cross-correlation assay for ligand-receptor binding: cell membrane nanopatches containing the human micro-opioid receptor Anal. Chem. 79 2007 6783 6791 (Pubitemid 47395067)
300. G. Balboni, S. Salvadori, A. Dal Piaz, F. Bortolotti, R. Argazzi, L. Negri, R. Lattanzi, S.D. Bryant, Y. Jinsmaa, and L.H. Lazarus Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic J. Med. Chem. 47 2004 6541 6546 (Pubitemid 39657316)
301. R.A. Houghten, C.T. Dooley, and J.R. Appel De novo identification of highly active fluorescent kappa opioid ligands from a rhodamine labeled tetrapeptide positional scanning library Bioorg. Med. Chem. Lett. 14 2004 1947 1951 (Pubitemid 38410870)
302. J.S. Josan, D.L. Morse, L. Xu, M. Trissal, B. Baggett, P. Davis, J. Vagner, R.J. Gillies, and V.J. Hruby Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging Org. Lett. 11 2009 2479 2482
303. K. Zhao, G. Luo, G.M. Zhao, P.W. Schiller, and H.H. Szeto Transcellular transport of a highly polar 3 + net charge opioid tetrapeptide J. Pharmacol. Exp. Ther. 304 2003 425 432 (Pubitemid 36008956)
304. V.M. Kolb, A. Koman, and L. Terenius Fluorescent probes for opioid receptors Life Sci. 33 Suppl. 1 1983 423 426 (Pubitemid 14249977)
305. T. Kshirsagar, A.H. Nakano, P.Y. Law, R. Elde, and P.S. Portoghese NTI4F: a non-peptide fluorescent probe selective for functional delta opioid receptors Neurosci. Lett. 249 1998 83 86 (Pubitemid 28331521)
306. M.E. Vazquez, J.B. Blanco, S. Salvadori, C. Trapella, R. Argazzi, S.D. Bryant, Y. Jinsmaa, L.H. Lazarus, L. Negri, E. Giannini, R. Lattanzi, M. Colucci, and G. Balboni 6-N, N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides J. Med. Chem. 49 2006 3653 3658 (Pubitemid 43902470)
307. T. Tokimoto, T.R. Bethea, M. Zhou, I. Ghosh, and M.J. Wirth Probing orientations of single fluorescent labels on a peptide reversibly binding to the human delta-opioid receptor Appl. Spectrosc. 61 2007 130 137 (Pubitemid 46347121)
308. B. Mouillac, M. Manning, and T. Durroux Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies Mini Rev. Med. Chem. 8 2008 996 1005
309. S. Terrillon, L.L. Cheng, S. Stoev, B. Mouillac, C. Barberis, M. Manning, and T. Durroux Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors J. Med. Chem. 45 2002 2579 2588 (Pubitemid 34595228)
310. M. Manning, A. Misicka, A. Olma, K. Bankowski, S. Stoev, B. Chini, T. Durroux, B. Mouillac, M. Corbani, and G. Guillon Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics J. Neuroendocrinol. 24 2012 609 628
311. S. Chen, M.J. Webber, J.P. Vilardaga, A. Khatri, D. Brown, D.A. Ausiello, H.Y. Lin, and R. Bouley Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand Endocrinology 152 2011 3893 3904
312. C.M. Lewis, E.K. Dolence, Z. Zhang, and J.D. Rose Fluorescent vasotocin conjugate for identification of the target cells for brain actions of vasotocin Bioconjug. Chem. 15 2004 909 914 (Pubitemid 38981968)
313. J. Guo, L. Song, M. Liu, and M.J. Mahon Fluorescent ligand-directed co-localization of the parathyroid hormone 1 receptor with the brush-border scaffold complex of the proximal tubule reveals hormone-dependent changes in ezrin immunoreactivity consistent with inactivation Biochim. Biophys. Acta 1823 2012 2243 2253
314. W.J. Zhang, X. Luo, G. Song, X.Y. Wang, X.X. Shao, and Z.Y. Guo Design, recombinant expression and convenient A-chain N-terminal europium-labelling of a fully active human relaxin-3 analogue FEBS J. 279 2012 1505 1512
315. E. Lacivita, A.C. Masotti, M. Jafurulla, R. Saxena, N. Rangaraj, A. Chattopadhyay, N.A. Colabufo, F. Berardi, R. Perrone, and M. Leopoldo Identification of a red-emitting fluorescent ligand for in vitro visualization of human serotonin 5-HT(1A) receptors Bioorg. Med. Chem. Lett. 20 2010 6628 6632
316. E. Lacivita, M. Leopoldo, A.C. Masotti, C. Inglese, F. Berardi, R. Perrone, S. Ganguly, M. Jafurulla, and A. Chattopadhyay Synthesis and characterization of environment-sensitive fluorescent ligands for human 5-HT1A receptors with 1-arylpiperazine structure J. Med. Chem. 52 2009 7892 7896
317. E. Lacivita, and M. Leopoldo N-[omega-[4-(2-methoxyphenyl)-1-piperazinyl] alkyl] -2-quinolinamines as high-affinity fluorescent 5-HT1A receptor ligands J. Med. Chem. 51 2008 1492 1495 (Pubitemid 351480412)
318. I. Berque-Bestel, J.L. Soulier, M. Giner, L. Rivail, M. Langlois, and S. Sicsic Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors J. Med. Chem. 46 2003 2606 2620 (Pubitemid 36702530)
319. G. Fricker, S. Nobmann, and D.S. Miller Permeability of porcine blood brain barrier to somatostatin analogues Br. J. Pharmacol. 135 2002 1308 1314 (Pubitemid 34259133)
320. V.K. Sreenivasan, O.A. Stremovskiy, T.A. Kelf, M. Heblinski, A.K. Goodchild, M. Connor, S.M. Deyev, and A.V. Zvyagin Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist Bioconjug. Chem. 22 2011 1768 1775
321. R.C. Patel, U. Kumar, D.C. Lamb, J.S. Eid, M. Rocheville, M. Grant, A. Rani, T. Hazlett, S.C. Patel, E. Gratton, and Y.C. Patel Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 3294 3299 (Pubitemid 34240625)
322. R.C. Patel, D.C. Lange, and Y.C. Patel Photobleaching fluorescence resonance energy transfer reveals ligand-induced oligomer formation of human somatostatin receptor subtypes Methods 27 2002 340 348
323. W.B. Edwards, B. Xu, W. Akers, P.P. Cheney, K. Liang, B.E. Rogers, C.J. Anderson, and S. Achilefu Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor Bioconjug. Chem. 19 2008 192 200 (Pubitemid 351213851)
324. K. Licha, C. Hessenius, A. Becker, P. Henklein, M. Bauer, S. Wisniewski, B. Wiedenmann, and W. Semmler Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes Bioconjug. Chem. 12 2001 44 50 (Pubitemid 32111452)
325. K.M. Jenkinson, J.M. Morgan, J.B. Furness, and B.R. Southwell Neurons bearing NK(3) tachykinin receptors in the guinea-pig ileum revealed by specific binding of fluorescently labelled agonists Histochem. Cell Biol. 112 1999 233 246 (Pubitemid 29475993)
326. C.G. Bradshaw, K. Ceszkowski, G. Turcatti, I.J. Beresford, and A. Chollet Synthesis and characterization of selective fluorescent ligands for the neurokinin NK2 receptor J. Med. Chem. 37 1994 1991 1995 (Pubitemid 24233612)
327. G. Turcatti, K. Nemeth, M.D. Edgerton, J. Knowles, H. Vogel, and A. Chollet Fluorescent labeling of NK2 receptor at specific sites in vivo and fluorescence energy transfer analysis of NK2 ligand-receptor complexes Receptors Channels 5 1997 201 207 (Pubitemid 28242958)
328. C. Valant, E. Maillet, J.J. Bourguignon, B. Bucher, V. Utard, J.L. Galzi, and M. Hibert Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration J. Med. Chem. 52 2009 5999 6011
329. R. Ashworth, R. Yu, E.J. Nelson, S. Dermer, M.C. Gershengorn, and P.M. Hinkle Visualization of the thyrotropin-releasing hormone receptor and its ligand during endocytosis and recycling Proc. Natl. Acad. Sci. U. S. A. 92 1995 512 516
330. C. Sherrill, O. Khouri, S. Zeman, and D. Roise Synthesis and biological activity of fluorescent yeast pheromones Biochemistry 34 1995 3553 3560
331. J.Y. Toshima, J. Nakanishi, K. Mizuno, J. Toshima, and D.G. Drubin Requirements for recruitment of a G protein-coupled receptor to clathrin-coated pits in budding yeast Mol. Biol. Cell 20 2009 5039 5050
332. J.Y. Toshima, J. Toshima, M. Kaksonen, A.C. Martin, D.S. King, and D.G. Drubin Spatial dynamics of receptor-mediated endocytic trafficking in budding yeast revealed by using fluorescent α-factor derivatives Proc. Natl. Acad. Sci. U. S. A. 103 2006 5793 5798